LYTIR

Company · TYRA

Tyra Biosciences, Inc.

Nasdaq's symbol directory lists TYRA on Nasdaq as “Tyra Biosciences, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($20K); 6 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Verjee Rehan bought on 1 day latest Sep 9, 2026 bought $20K
Every trade (1)
  1. BUYVerjee Rehan bought Sep 9, 2026 971 shares filing $20K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G/A passive 3,304,658 shares filing 4.8%
  2. BIOTECHNOLOGY VALUE FUND L P filed Sep 21, 2026 Schedule 13G passive filing 6.1%
  3. RA Capital Management, L.P. filed Sep 17, 2026 Schedule 13D/A may seek influence 14,130,492 shares filing 19.9%
  4. Paradigm BioCapital Advisors LP filed Sep 17, 2026 Schedule 13G passive filing 5.8%
  5. Nextech VI Oncology SCSp filed Aug 14, 2026 Schedule 13G/A passive filing 6%
  6. Farallon Capital Management, L.L.C. filed Aug 14, 2026 Schedule 13G/A passive filing 0%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Sep 15, 2026
  2. Other events filing Sep 9, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.